Exact Mass: 392.1543
Exact Mass Matches: 392.1543
Found 500 metabolites which its exact mass value is equals to given mass value 392.1543
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sparfloxacin
Sparfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections. Sparfloxacin exerts its antibacterial activity by inhibiting DNA gyrase, a bacterial topoisomerase. DNA gyrase is an essential enzyme which controls DNA topology and assists in DNA replication, repair, deactivation, and transcription. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
7-Ethyl-10-hydroxycamptothecin
SN-38 is a member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. It has a role as an apoptosis inducer, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a drug metabolite and an antineoplastic agent. It is a pyranoindolizinoquinoline, a delta-lactone, a tertiary alcohol and a member of phenols. 7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan [DB00762], a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer. SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others. 7-Ethyl-10-hydroxycamptothecin is a natural product found in Apis cerana with data available. A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin (SN38) is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor); it is 1000 times more active than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold. SN38 is metabolized via glucoronidation by UGT1A1. (Wikipedia) 7-Ethyl-10-hydroxycamptothecin (SN38), the active metabolite of irinotecan, exerts a 100-fold to 1000-fold higher effect than irinotecan itself against several tumor cell lines. (PMID: 23233044) Among five chemotherapeutic agents commonly used for breast cancer treatment, only an irinotecan metabolite SN38 showed additive antitumor activity with olaparib. (PMID: 22454224) Metabolism of irinotecan to SN38 is inefficient and subject to considerable patient-to-patient variability. One approach to more controlled administration of the anticancer agent is direct administration of the active SN38. (PMID: 23299391) A member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively[1][2][3][4]. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively[1][2][3][4].
1,1'-Bis(2-hydroxy-3-methylcarbazole)
1,1-Bis(2-hydroxy-3-methylcarbazole) is found in herbs and spices. 1,1-Bis(2-hydroxy-3-methylcarbazole) is an alkaloid from roots of Murraya koenigii (curryleaf tree). Alkaloid from roots of Murraya koenigii (curryleaf tree). 1,1-Bis(2-hydroxy-3-methylcarbazole) is found in herbs and spices.
Calabaxanthone
Calabaxanthone is found in fruits. Calabaxanthone is a constituent of Garcinia mangostana (mangosteen)
Marmesin rhamnoside
Marmesin rhamnoside is found in fruits. Marmesin rhamnoside is isolated from the stem bark of Aegle marmelos (bael fruit). Isolated from the stem bark of Aegle marmelos (bael fruit). Marmesin rhamnoside is found in fruits.
Cloprednol
4-Amino-5-[[2-[[1-chloro-6-(diaminomethylideneamino)-2-oxohexan-3-yl]amino]acetyl]amino]-5-oxopentanoic acid
Mardepodect
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
Reglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
2-[1-[(2S)-2-[[4-[(E)-N'-Hydroxycarbamimidoyl]benzoyl]amino]propanoyl]piperidin-4-yl]oxyacetic acid
Vellein
Vellein is a member of the class of compounds known as coumarin glycosides. Coumarin glycosides are aromatic compounds containing a carbohydrate moiety glycosidically bound to a coumarin moiety. Vellein is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Vellein can be found in wild celery, which makes vellein a potential biomarker for the consumption of this food product.
8beta-Tigloyloxy-2,3-seco-4Z,11(13)-heliangadiene-3,10beta:6,12-diolid-2-oic acid
6-Butyryl-5,7-dihydroxy-8- (3,3-dimethylallyl) -4-phenylcoumarin
3,5-Dimethoxy-4-[alpha-(hydroxymethyl)-beta,4-dihydroxy-3-methoxyphenethyloxy]acetophenone
erythro-dihydroxydehydrodiconiferyl alcohol|sisymbrifolin|threo-dihydroxydehydrodiconiferyl alcohol
5beta,9alpha-dihydroxy-4,5-dihydroatripliciolide-8-O-angelate
3,4-dihydro-ruine|7-methoxy-1-methyl-4,9-dihydro-3H-beta-carbolin-8-yl beta-D-glucopyranoside|Dihydroruine
2-O-decoumaroylaloeresin G|2-(E)-propenyl-7-methoxy-8-C-beta-D-glucopyranosyl-5-methylchromone
4beta,15-epox-desacylmiller-9E-enolide-8-O-angelate
6-O-trans-p-coumaroyl-1beta-O-methylovatofuranic acid methyl ester|6-O-trans-p-Coumaroyl-1??-O-methylovatofuranic acid methyl ester
1-Keto-3,10-epoxy-11??-methoxymethyl-8??-O-methacryloyl-15-hydroxy-2,4-germacradiene,6??,12-olide
7-beta-D-glucopyranosyloxy-6-prenyl coumarin|7-beta-D-glucopyranosyloxy-6-prenylcoumarin
(2R,3R)-8alpha-(2,3-epoxy-2-methylbutyryloxy)-4alpha,9alpha-epidioxy-9beta-hydroxy-5betaH-eudesm-1,11(13)-dien-6beta,12-olide
4-[alpha-(Hydroxymethyl)-4,beta-dihydroxy-3-methoxyphenethyloxy]-3-methoxy-beta-hydroxypropiophenone
5-desoxy-8-deacetyleuparotin-8-O-(4,5-dihydroxytiglate)|5-desoxy-8-deacetyleuparotin-8-O-<4,5-dihydroxytiglate>
6alpha-(2-methyl-2,3-epoxybutyryloxy)-5beta-hydroxy-4(15)-goyazensanolide
(-)-cis-cleroda-3,13-dien-12,15-dihydroxy-16,17,18-trioic acid-16,15:18,6alpha-diolide
Bis(4-hydroxybenzyl)ether mono-??-D-glucopyranoside|gastrodioside
(5S,6R,7R,8S,10R)-3-acetoxy-8-O-(3-hydroxy-2-methylene-propanoyloxy)-14,15-dihydroxy-elema-1,3,11(13)-triene-12,6-olide|hierapolitanin B
2-(3,3-Dihydroxy-4,4-dimethoxybenzhydryl)-3-hydroxymethyl-4-hydroxybutyric acid
9alpha-hydroxy-11,13-dehydroleucodin-9-O-beta-xylopyranoside
7-beta-D-glucopyranosyloxy-8-(3-methyl-but-2-enyl)-coumarin|7-beta-D-Glucopyranosyloxy-8-(3-methyl-but-2-enyl)-cumarin|7-O-beta-D-glucopyranosyloxy-8-prenyl coumarin|7-O-beta-D-glucopyranosyloxy-8-prenylcoumarin|osthenol-7-O-beta-D-glucoside
OZESIOWEPLUEAF-QFIPXVFZSA-N
12-Ethyl-9-hydroxycamptothecin is a derivative of Camptothecin. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM[1].
Sparfloxacin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
C20H24O8_1H-2-Benzopyran-6-acetic acid, 8a-ethenyloctahydro-5-hydroxy-7-[[2-(hydroxymethyl)-1-oxo-2-propen-1-yl]oxy]-alpha,4-bis(methylene)-3-oxo-, methyl ester, (5R,6S,7S,8aR)
[(5R,6S,7S,8aR)-8a-ethenyl-5-hydroxy-6-(3-methoxy-3-oxoprop-1-en-2-yl)-4-methylidene-3-oxo-1,4a,5,6,7,8-hexahydroisochromen-7-yl] 2-(hydroxymethyl)prop-2-enoate
[(5R,6S,7S,8aR)-8a-ethenyl-5-hydroxy-6-(3-methoxy-3-oxoprop-1-en-2-yl)-4-methylidene-3-oxo-1,4a,5,6,7,8-hexahydroisochromen-7-yl] 2-(hydroxymethyl)prop-2-enoate_major
Ala Asp Ser Thr
Ala Asp Thr Ser
Ala Glu Ser Ser
Ala Ser Asp Thr
Ala Ser Glu Ser
Ala Ser Ser Glu
Ala Ser Thr Asp
Ala Thr Asp Ser
Ala Thr Ser Asp
Asp Ala Ser Thr
Asp Ala Thr Ser
Asp Gly Thr Thr
Asp Ser Ala Thr
Asp Ser Thr Ala
Asp Thr Ala Ser
Asp Thr Gly Thr
Asp Thr Ser Ala
Asp Thr Thr Gly
Glu Ala Ser Ser
Glu Gly Met Gly
Glu Gly Ser Thr
Glu Gly Thr Ser
Glu Met Gly Gly
Glu Ser Ala Ser
Glu Ser Gly Thr
Glu Ser Ser Ala
Glu Ser Thr Gly
Glu Thr Gly Ser
Glu Thr Ser Gly
b-D-Glucopyranosiduronic acid, 3-(6-hydroxy-2-naphthalenyl)-1-methylpropyl
b-D-Glucopyranosiduronic acid, 6-(3-hydroxybutyl)-2-naphthalenyl
Gly Ala Asp Met
Gly Ala Met Asp
Gly Cys Asp Val
Gly Cys Val Asp
Gly Asp Ala Met
Gly Asp Cys Val
Gly Asp Met Ala
Gly Asp Thr Thr
Gly Asp Val Cys
Gly Glu Gly Met
Gly Glu Met Gly
Gly Glu Ser Thr
Gly Glu Thr Ser
Gly Gly Glu Met
Gly Gly Met Glu
Gly Gly Pro Tyr
Gly Gly Tyr Pro
Gly Met Ala Asp
Gly Met Asp Ala
Gly Met Glu Gly
Gly Met Gly Glu
Gly Pro Gly Tyr
Gly Pro Tyr Gly
Gly Ser Glu Thr
Gly Ser Thr Glu
Gly Thr Asp Thr
Gly Thr Glu Ser
Gly Thr Ser Glu
Gly Thr Thr Asp
Gly Val Cys Asp
Gly Val Asp Cys
Gly Tyr Gly Pro
Gly Tyr Pro Gly
Met Ala Asp Gly
Met Ala Gly Asp
Met Asp Ala Gly
Met Asp Gly Ala
Met Glu Gly Gly
Met Gly Ala Asp
Met Gly Asp Ala
Met Gly Glu Gly
Met Gly Gly Glu
Pro Cys Ser Ser
Pro Gly Gly Tyr
Pro Gly Tyr Gly
Pro Ser Cys Ser
Pro Ser Ser Cys
Pro Tyr Gly Gly
Ser Ala Asp Thr
Ser Ala Glu Ser
Ser Ala Ser Glu
Ser Ala Thr Asp
Ser Cys Pro Ser
Ser Cys Ser Pro
Ser Asp Ala Thr
Ser Asp Thr Ala
Ser Glu Ala Ser
Ser Glu Gly Thr
Ser Glu Ser Ala
Ser Glu Thr Gly
Ser Gly Glu Thr
Ser Gly Thr Glu
Ser Pro Cys Ser
Ser Pro Ser Cys
Ser Ser Ala Glu
Ser Ser Cys Pro
Ser Ser Glu Ala
Ser Ser Pro Cys
Ser Thr Ala Asp
Ser Thr Asp Ala
Ser Thr Glu Gly
Ser Thr Gly Glu
Thr Ala Asp Ser
Thr Ala Ser Asp
Thr Asp Ala Ser
Thr Asp Gly Thr
Thr Asp Ser Ala
Thr Asp Thr Gly
Thr Glu Gly Ser
Thr Glu Ser Gly
Thr Gly Asp Thr
Thr Gly Glu Ser
Thr Gly Ser Glu
Thr Gly Thr Asp
Thr Ser Ala Asp
Thr Ser Asp Ala
Thr Ser Glu Gly
Thr Ser Gly Glu
Thr Thr Asp Gly
Thr Thr Gly Asp
Val Cys Asp Gly
Val Cys Gly Asp
Val Asp Cys Gly
Val Asp Gly Cys
Val Gly Cys Asp
Val Gly Asp Cys
Tyr Gly Gly Pro
Tyr Gly Pro Gly
Tyr Pro Gly Gly
6-Butyryl-5,7-dihydroxy-8-(3,3-dimethylallyl)-4-phenylcoumarin
Calabaxanthone
Marmesin rhamnoside
1,1'-Bis(2-hydroxy-3-methylcarbazole)
Sulfurous acid, ester, 2-chloroethyl-2-[2-[4-(1,1-dimethylethyl)phenoxy]-1-methylethoxy]-1-methylethyl ester
L-Serine,N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, 2,5-dioxo-1-pyrrolidinylester
4-benzoyl-2-methyl-1-[(7-oxido-1h-pyrrolo[2,3-b] pyridin-3-yl)oxoacetyl]-piperazine
2,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-b]thiophene
4-{4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZIN-1-YL}BENZALDEHYDE
(3E)-2-(Diphenylacetyl)-3-[(2E)-2-propen-1-ylidenehydrazono]-1-in danone
Chloroprednisone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
cloprednol
H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Decernotinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
(E)-2-cyano-N-(2-methoxyphenyl)-3-(5-nitro-2-pyrrolidin-1-ylphenyl)prop-2-enamide
3-(4-Benzoyl-piperazine-1-carbonyl)-8-methoxy-chromen-2-one
2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline
Reglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
Mardepodect
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
H-Glu-Gly-Arg-chloromethylketone
D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones
1-[(3,4-Dimethoxyphenyl)sulfonyl]-4-(2-methoxyphenyl)piperazine
3-Butyl-8-(2-fluorophenyl)-7-(phenylmethyl)purine-2,6-dione
C-2-decoumaroyl-aloeresin G
A member of the class of chromones that is chromone substituted by a methoxy group at position 7, a methyl group at position 5, a propenyl group at position 2 and a beta-D-glucopyranosyl residue at position 8 via a C-glycosidic linkage. It has been isolated from Aloe vera.
2-Chloro-1-[4-(2-ethyl-7-methyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)piperazin-1-yl]ethanone
3-[[(2-Cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid
4-(5-Ethyl-4-phenyl-1,3-thiazol-2-yl)-10-(1-methylethylidene)-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione
2-[[[4-[(3-methylanilino)-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]acetic acid (phenylmethyl) ester
1-(2,3-dihydro-1H-inden-2-yl)-4-(2-naphthalenylsulfonyl)piperazine
[(2R,3S,4S)-4-(ethylaminomethyl)-3-[4-(4-fluorophenyl)phenyl]-1-methylsulfonyl-2-azetidinyl]methanol
[(2S,3R)-3-phenyl-1-(3-pyridinylmethyl)-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[(2S,3S)-3-phenyl-1-(3-pyridinylmethyl)-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
4-[[(E,6R)-6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhept-2-enoyl]amino]benzoate
6,7,8,15,16,17-Hexahydro-7,16-methano-19-oxocyclodeca[1,2-b:6,7-b]dinaphthalene-5,18-dione
1-(2-hydroxy-3-methyl-9H-carbazol-1-yl)-3-methyl-9H-carbazol-2-ol
7-ethyl-10-hydroxycamptothecin
1-[(2s,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propane-1,2,3-triol
(3ar,4r,6as,9ar,9bs)-6a-hydroperoxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2e)-4-hydroxy-2-(hydroxymethyl)but-2-enoate
7-[(2s,3r)-2,3-dihydroxy-3-methyl-4-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]butoxy]-8-methoxychromen-2-one
(3z,8s,11e,16s)-8,16-bis(2-oxopropyl)-1,9-dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone
(5s)-5-(furan-3-yl)-5-hydroxy-2-[(1r,5s,9s,11r)-9-hydroxy-4-oxo-3,10-dioxatricyclo[7.3.0.0¹,⁵]dodecan-11-yl]-3-methylpent-2-enoic acid
1-(4-{[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)-3-hydroxypropan-1-one
(3r,4r,5s)-3-[(s)-hydroxy(4-hydroxy-3-methoxyphenyl)methyl]-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-ol
8,16-bis(2-oxopropyl)-1,9-dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone
(1r,6r,13s)-16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
8-butanoyl-5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)-4-phenylchromen-2-one
(1'r,2s,2'r,4'r,5'r,5''s,6'r,9'r)-5''-(furan-3-yl)-2',6',9'-trihydroxy-4'-methyldispiro[oxirane-2,12'-[10]oxatricyclo[7.2.1.0¹,⁶]dodecane-5',3''-oxolan]-2''-one
(1r,2r,4r,5r,7s,9z,11r)-4-hydroxy-9-(hydroxymethyl)-4-methyl-14-methylidene-8,13-dioxo-6,12-dioxatricyclo[9.3.0.0⁵,⁷]tetradec-9-en-2-yl (2z)-2-methylbut-2-enoate
[(1s,6s,7r,11s,13r,16r,17s)-7-hydroxy-6,10,16-trimethyl-4,8,15-trioxo-3,14-dioxatetracyclo[11.4.0.0¹,⁵.0⁶,¹¹]heptadec-9-en-17-yl]acetic acid
(1s,2r,4r,5s,6r,10z,13s,14s)-5,6-dihydroxy-11-methyl-7-methylidene-4-[(2r)-2-methyloxiran-2-yl]-15,17,18-trioxatetracyclo[11.2.2.1²,⁶.0¹,¹⁴]octadec-10-ene-9,16-dione
7-[(4,9-dioxodeca-2,7-dienoyl)oxy]-4,9-dioxodec-2-enoic acid
(2z,5s)-5-(furan-3-yl)-5-hydroxy-2-[(1r,5s,9s,11r)-9-hydroxy-4-oxo-3,10-dioxatricyclo[7.3.0.0¹,⁵]dodecan-11-yl]-3-methylpent-2-enoic acid
1-(4-{[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)ethanone
3-[2-methyl-5-oxo-3-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)oxolan-2-yl]propanoic acid
5,12,17-trihydroxy-6,14,18-trimethyl-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁵,¹⁹.0¹³,¹⁸]nonadec-14-ene-4,9,16-trione
7-[(2s,3s)-2,3-dihydroxy-3-methyl-4-[(2s,4r)-4-methyl-5-oxooxolan-2-yl]butoxy]-8-methoxychromen-2-one
1,7,11-trihydroxy-9,14-dimethyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-9-en-8-yl 2-methylbut-2-enoate
n-{3-[2-amino-3-(4-hydroxyphenoxy)phenyl]-3-oxopropyl}-4-hydroxybenzamide
4,5,12,17-tetrahydroxy-14,18-dimethyl-6-methylidene-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-ene-9,16-dione
8-(3-methylbut-2-en-1-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
(1r,4s,7s,8r,11z,13s,14s)-8-acetyl-8,11-dimethyl-3,10-dioxo-2,6,9-trioxatricyclo[5.5.2.0⁴,¹³]tetradec-11-en-14-yl (2z)-2-methylbut-2-enoate
(1r,2r,4r,5s,6r,10e,13s)-5,6-dihydroxy-11-methyl-7-methylidene-4-[(2s)-2-methyloxiran-2-yl]-15,17,18-trioxatetracyclo[11.2.2.1²,⁶.0¹,¹⁴]octadec-10-ene-9,16-dione
8-acetyl-8,11-dimethyl-3,10-dioxo-2,6,9-trioxatricyclo[5.5.2.0⁴,¹³]tetradec-11-en-14-yl 2-methylbut-2-enoate
(1s,2r,3r,7s,8r,9r,12s)-9-hydroxy-1,12-dimethyl-6-methylidene-5-oxo-4,10,11-trioxatetracyclo[7.6.0.0²,¹².0³,⁷]pentadec-14-en-8-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(3ar,4r,7r,10r,11r,11as)-6-formyl-11-hydroxy-7-methoxy-3-methylidene-2-oxo-4,7,8,9,11,11a-hexahydro-3ah-spiro[cyclodeca[b]furan-10,2'-oxiran]-4-yl 2-methylprop-2-enoate
(1r,2r,4r,5s,6r,10e,13s,14s)-5,6-dihydroxy-11-methyl-7-methylidene-4-[(2s)-2-methyloxiran-2-yl]-15,17,18-trioxatetracyclo[11.2.2.1²,⁶.0¹,¹⁴]octadec-10-ene-9,16-dione
10-epieupatoroxin
{"Ingredient_id": "HBIN000112","Ingredient_name": "10-epieupatoroxin","Alias": "NA","Ingredient_formula": "C20H24O8","Ingredient_Smile": "CC=C(C)C(=O)OC1CC2(CO2)C3C(C4C(C3(C5C1C(=C)C(=O)O5)O)(O4)C)O","Ingredient_weight": "392.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6912","TCMSP_id": "NA","TCM_ID_id": "9435;21350","PubChem_id": "118701552","DrugBank_id": "NA"}
6-o-cis-p-coumaroyl-1β-o-methylovatofuranicacid methyl ester
{"Ingredient_id": "HBIN012655","Ingredient_name": "6-o-cis-p-coumaroyl-1\u03b2-o-methylovatofuranicacid methyl ester","Alias": "NA","Ingredient_formula": "C20H24O8","Ingredient_Smile": "COC1C2C(C(CC2(CO1)O)OC(=O)C=CC3=CC=C(C=C3)O)CC(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4175","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-trans-p-coumaroyl-1β-o-methylovato-furanicacid methyl ester
{"Ingredient_id": "HBIN012720","Ingredient_name": "6-o-trans-p-coumaroyl-1\u03b2-o-methylovato-furanicacid methyl ester","Alias": "NA","Ingredient_formula": "C20H24O8","Ingredient_Smile": "COC1C2C(C(CC2(CO1)O)OC(=O)C=CC3=CC=C(C=C3)O)CC(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4176","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8β-tigloyloxy-2,3-seco-6βh,7αh-helianga-4z,11(13)-diene-3,10β;6,12-diolid-2-oicacid
{"Ingredient_id": "HBIN013675","Ingredient_name": "8\u03b2-tigloyloxy-2,3-seco-6\u03b2h,7\u03b1h-helianga-4z,11(13)-diene-3,10\u03b2;6,12-diolid-2-oicacid","Alias": "NA","Ingredient_formula": "C20H24O8","Ingredient_Smile": "CC(=CCO)C(=O)OC1CC2(CO2)C3C(C4C1C(=C)C(=O)O4)C5(C(C3O)O5)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21364","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bis(4-hydroxybenzyl)ether mono-beta-d-glucopyranoside
{"Ingredient_id": "HBIN018560","Ingredient_name": "bis(4-hydroxybenzyl)ether mono-beta-d-glucopyranoside","Alias": "bis(4-hydroxybenzyl)ether mono-\u03b2-d-glucopy-ranoside","Ingredient_formula": "C20H24O8","Ingredient_Smile": "C1=CC(=CC=C1COCC2=CC=C(C=C2)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30671;2459","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}